Systemic Anti-Cancer Therapy Regimen Library New Zealand Formulary

Respiratory Regimens

Mesothelioma Regimens

Published Sort regimens by
LUNG MESO Metastatic - cARBOplatin and pemetrexed Id: 52691000210106 Published date: Version: 2.0.0
52691000210106
2.0.0
05/07/2022
LUNG MESO Metastatic - cARBOplatin, pemetrexed and beVACizumab Id: 393361000210107 Published date: Version: 1.0.0
393361000210107
1.0.0
18/08/2024
LUNG MESO Metastatic - cISplatin and pemetrexed Id: 52711000210108 Published date: Version: 1.0.0
52711000210108
1.0.0
27/07/2021
LUNG MESO Metastatic - cISplatin, pemetrexed and beVACizumab Id: 393351000210109 Published date: Version: 1.0.0
393351000210109
1.0.0
18/08/2024
LUNG MESO Metastatic - gemcitabine Id: 506691000210103 Published date: Version: 1.0.0
506691000210103
1.0.0
26/02/2026
LUNG MESO Metastatic - nivolumab [Q2W] and ipilimumab [Q6W] Id: 392941000210102 Published date: Version: 1.0.0
392941000210102
1.0.0
26/06/2024
LUNG MESO Metastatic - nivolumab Q2W [flat dosing] Id: 506681000210100 Published date: Version: 1.0.0
506681000210100
1.0.0
26/02/2026
LUNG MESO Metastatic - nivolumab Q4W [flat dosing] Id: 506671000210102 Published date: Version: 1.0.0
506671000210102
1.0.0
26/02/2026
LUNG MESO Metastatic - pembrolizumab Q3W [flat dosing] Id: 506661000210108 Published date: Version: 1.0.0
506661000210108
1.0.0
26/02/2026
LUNG MESO Metastatic - pembrolizumab Q6W [flat dosing] Id: 506651000210105 Published date: Version: 1.0.0
506651000210105
1.0.0
26/02/2026
LUNG MESO Metastatic - vinORELBine Id: 52571000210106 Published date: Version: 1.0.0
52571000210106
1.0.0
29/06/2021
LUNG MESO Metastatic - vinORELBine [oral] Id: 393691000210107 Published date: Version: 1.0.0
393691000210107
1.0.0
18/09/2024

NSCLC Regimens

Adjuvant & Neoadjuvant Regimens

Published Sort regimens by
LUNG NSCLC Adjuvant - aTEZOLIzumab Q3W Id: 497231000210106 Published date: Version: 1.0.0
497231000210106
1.0.0
20/03/2025
LUNG NSCLC Adjuvant - cISplatin and pemetrexed Id: 506261000210106 Published date: Version: 1.0.0
506261000210106
1.0.0
09/04/2025
LUNG NSCLC Adjuvant - cISplatin and vinORELBine [oral] Q3W Id: 496701000210107 Published date: Version: 2.0.0
496701000210107
2.0.0
07/05/2026
LUNG NSCLC Adjuvant - cISplatin and vinORELBine Q3W Id: 58921000210103 Published date: Version: 2.0.0
58921000210103
2.0.0
07/05/2026
LUNG NSCLC Adjuvant - cISplatin and vinORELBine [oral] Q4W Id: 496691000210107 Published date: Version: 2.0.0
496691000210107
2.0.0
07/05/2026
LUNG NSCLC Adjuvant - cISplatin and vinORELBine Q4W Id: 58981000210102 Published date: Version: 2.0.0
58981000210102
2.0.0
07/05/2026
LUNG NSCLC Adjuvant - osimertinib Id: 263821000210103 Published date: Version: 1.0.0
263821000210103
1.0.0
28/03/2023
LUNG NSCLC Neoadjuvant - cARBOplatin, PACLItaxel and nivolumab Id: 506631000210104 Published date: Version: 1.0.0
506631000210104
1.0.0
26/02/2026
LUNG NSCLC Neoadjuvant - cISplatin, gemcitabine and nivolumab Id: 393251000210102 Published date: Version: 2.0.0
393251000210102
2.0.0
08/05/2026
LUNG NSCLC Neoadjuvant - cISplatin, pemetrexed and nivolumab Id: 393241000210100 Published date: Version: 1.0.0
393241000210100
1.0.0
18/08/2024

Definitive Regimens

Published Sort regimens by
LUNG NSCLC Definitive - cARBOplatin and PACLItaxel chemoradiation Id: 58901000210106 Published date: Version: 2.0.0
58901000210106
2.0.0
01/08/2024
LUNG NSCLC Definitive - cISplatin and etoposide chemoradiation Id: 52851000210100 Published date: Version: 4.0.0
52851000210100
4.0.0
08/05/2026
LUNG NSCLC Definitive - [Superior sulcus Pancoast] cISplatin and etoposide chemoradiation Id: 52841000210103 Published date: Version: 4.0.0
52841000210103
4.0.0
08/05/2026
LUNG NSCLC Definitive - cISplatin and gemcitabine chemoradiation Id: 59291000210101 Published date: Version: 2.0.0
59291000210101
2.0.0
08/05/2026
LUNG NSCLC Definitive - cISplatin and pemetrexed chemoradiation Id: 393681000210105 Published date: Version: 1.0.0
393681000210105
1.0.0
18/09/2024
LUNG NSCLC Definitive - cISplatin and vinBLASTine chemoradiation Id: 59271000210100 Published date: Version: 2.0.0
59271000210100
2.0.0
08/05/2026

Locally advanced & Metastatic Regimens

Published Sort regimens by
LUNG NSCLC Locally advanced - durvalumab Q2W [weight based dosing] Id: 59901000210101 Published date: Version: 2.0.0
59901000210101
2.0.0
29/04/2025
LUNG NSCLC Locally advanced - durvalumab Q4W [flat dosing] Id: 264071000210108 Published date: Version: 2.0.0
264071000210108
2.0.0
29/04/2025
LUNG NSCLC Locally advanced/Metastatic - aFATinib Id: 497241000210103 Published date: Version: 1.0.0
497241000210103
1.0.0
20/03/2025
LUNG NSCLC Locally advanced/Metastatic - alectinib Id: 393341000210106 Published date: Version: 1.0.0
393341000210106
1.0.0
20/08/2025
LUNG NSCLC Locally advanced/Metastatic - amivantamab Id: 496721000210104 Published date: Version: 2.0.0
Components ▾
amivantamab 1050 mg Id: 496731000210102 Published date: Version: 0.0.14
amivantamab 1400mg Id: 496741000210105 Published date: Version: 0.0.15
496721000210104
2.0.0
26/02/2026
LUNG NSCLC Locally advanced/Metastatic - aTEZOLIzumab Q3W Id: 393331000210103 Published date: Version: 1.0.0
393331000210103
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - brigatinib Id: 393321000210100 Published date: Version: 1.0.0
393321000210100
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - cARBOplatin and gemcitabine Id: 264751000210103 Published date: Version: 1.0.0
264751000210103
1.0.0
05/07/2023
LUNG NSCLC Locally advanced/Metastatic - cARBOplatin and vinORELBine Id: 264741000210101 Published date: Version: 1.0.0
264741000210101
1.0.0
05/07/2023
LUNG NSCLC Locally advanced/Metastatic - cARBOplatin and vinORELBine [oral] Id: 496751000210108 Published date: Version: 1.0.0
496751000210108
1.0.0
29/01/2025
LUNG NSCLC Locally advanced/Metastatic - crizotinib Id: 393311000210105 Published date: Version: 1.0.0
393311000210105
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - Enhertu [trastuzumab deruxtecan] Id: 393621000210109 Published date: Version: 1.0.0
393621000210109
1.0.0
05/09/2024
LUNG NSCLC Locally advanced/Metastatic - entrectinib Id: 393301000210108 Published date: Version: 1.0.0
393301000210108
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - erlotinib Id: 497251000210100 Published date: Version: 1.0.0
497251000210100
1.0.0
20/03/2025
LUNG NSCLC Locally advanced/Metastatic - gefitinib Id: 497261000210102 Published date: Version: 1.0.0
497261000210102
1.0.0
20/03/2025
LUNG NSCLC Locally advanced/Metastatic - lorlatinib Id: 393291000210109 Published date: Version: 1.0.0
393291000210109
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - osimertinib Id: 393711000210109 Published date: Version: 1.0.0
393711000210109
1.0.0
30/09/2024
LUNG NSCLC Locally advanced/Metastatic - pralsetinib Id: 393281000210107 Published date: Version: 1.0.0
393281000210107
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - sotorasib Id: 506641000210107 Published date: Version: 1.0.0
506641000210107
1.0.0
26/02/2026
LUNG NSCLC Metastatic - biNIMEtinib and encorafenib Id: 506271000210100 Published date: Version: 1.0.0
506271000210100
1.0.0
09/04/2025
LUNG NSCLC Metastatic - cARBOplatin and DOCEtaxel Id: 52831000210106 Published date: Version: 2.0.0
52831000210106
2.0.0
05/07/2022
LUNG NSCLC Metastatic - cARBOplatin and PACLItaxel Id: 58891000210105 Published date: Version: 3.0.0
58891000210105
3.0.0
28/03/2023
LUNG NSCLC Metastatic - cARBOplatin and pemetrexed Id: 52821000210109 Published date: Version: 3.0.0
52821000210109
3.0.0
29/10/2023
LUNG NSCLC Metastatic - cARBOplatin and Q1W PACLItaxel Id: 52551000210103 Published date: Version: 2.0.0
52551000210103
2.0.0
19/09/2023
LUNG NSCLC Metastatic - cARBOplatin, gemcitabine and pembrolizumab Id: 506621000210101 Published date: Version: 1.0.0
506621000210101
1.0.0
26/02/2026
LUNG NSCLC Metastatic - cARBOplatin, PACLItaxel and pembrolizumab Id: 52651000210104 Published date: Version: 3.0.0
52651000210104
3.0.0
28/03/2023
LUNG NSCLC Metastatic - cARBOplatin, PACLItaxel, aTEZOLIzumab and beVACizumab Id: 52641000210102 Published date: Version: 3.0.0
52641000210102
3.0.0
28/03/2023
LUNG NSCLC Metastatic - cARBOplatin, pemetrexed and pembrolizumab Id: 52671000210107 Published date: Version: 3.0.0
52671000210107
3.0.0
29/10/2023
LUNG NSCLC Metastatic - cISplatin and gemcitabine Id: 59281000210103 Published date: Version: 2.0.0
59281000210103
2.0.0
08/05/2026
LUNG NSCLC Metastatic - cISplatin and pemetrexed Id: 58941000210109 Published date: Version: 2.0.0
58941000210109
2.0.0
29/10/2023
LUNG NSCLC Metastatic - cISplatin and vinORELBine Id: 58911000210108 Published date: Version: 2.0.0
58911000210108
2.0.0
07/05/2026
LUNG NSCLC Metastatic - cISplatin and vinORELBine [oral] Id: 496771000210100 Published date: Version: 2.0.0
496771000210100
2.0.0
07/05/2026
LUNG NSCLC Metastatic - daBRAFEnib and tRAMEtinib Id: 52741000210109 Published date: Version: 3.0.0
52741000210109
3.0.0
17/10/2022
LUNG NSCLC Metastatic - DOCEtaxel Q1W Id: 52801000210101 Published date: Version: 1.0.0
52801000210101
1.0.0
06/08/2021
LUNG NSCLC Metastatic - DOCEtaxel Q3W Id: 52811000210104 Published date: Version: 1.0.0
52811000210104
1.0.0
06/08/2021
LUNG NSCLC Metastatic - gemcitabine Id: 263831000210101 Published date: Version: 2.0.0
263831000210101
2.0.0
29/10/2023
LUNG NSCLC Metastatic - nivolumab Q2W [flat dosing] Id: 52701000210106 Published date: Version: 3.0.0
52701000210106
3.0.0
17/10/2022
LUNG NSCLC Metastatic - nivolumab Q2W [weight based dosing] Id: 52751000210107 Published date: Version: 1.0.0
52751000210107
1.0.0
27/07/2021
LUNG NSCLC Metastatic - nivolumab Q4W [flat dosing] Id: 52761000210105 Published date: Version: 3.0.0
52761000210105
3.0.0
17/10/2022
LUNG NSCLC Metastatic - PACLItaxel Q1W Id: 52681000210109 Published date: Version: 3.0.0
52681000210109
3.0.0
28/03/2023
LUNG NSCLC Metastatic - PACLItaxel Q1W Id: 52681000210109 Published date: Version: 3.0.0
52681000210109
3.0.0
28/03/2023
LUNG NSCLC Metastatic - pembrolizumab Q3W [flat dosing] Id: 263901000210104 Published date: Version: 1.0.0
263901000210104
1.0.0
28/03/2023
LUNG NSCLC Metastatic - pembrolizumab Q6W [flat dosing] Id: 393261000210104 Published date: Version: 1.0.0
393261000210104
1.0.0
18/08/2024
LUNG NSCLC Metastatic - vinORELBine 25 Q1W Id: 264221000210100 Published date: Version: 1.0.0
264221000210100
1.0.0
19/04/2023
LUNG NSCLC Metastatic - vinORELBine 30 [day 1 and 8] Q3W Id: 264231000210103 Published date: Version: 1.0.0
264231000210103
1.0.0
19/04/2023
LUNG NSCLC Metastatic - vinORELBine [oral] 60 Q1W Id: 393661000210102 Published date: Version: 1.0.0
393661000210102
1.0.0
18/09/2024
LUNG NSCLC Metastatic - vinORELBine [oral] 60 [day 1 and 8] Q3W Id: 393671000210108 Published date: Version: 1.0.0
393671000210108
1.0.0
18/09/2024
Superseded Regimens Sort regimens by
LUNG NSCLC Advanced/Metastatic - alectinib Id: 52331000210102 Published date: Version: 3.0.2
52331000210102
3.0.2
29/03/2026
LUNG NSCLC Metastatic - aFATinib Id: 52721000210103 Published date: Version: 1.0.2
52721000210103
1.0.2
29/03/2026
LUNG NSCLC Metastatic - aTEZOLIzumab Id: 52731000210101 Published date: Version: 3.0.2
52731000210101
3.0.2
29/03/2026
LUNG NSCLC Metastatic - crizotinib Id: 52661000210101 Published date: Version: 1.0.2
52661000210101
1.0.2
29/03/2026
LUNG NSCLC Metastatic - erlotinib Id: 58951000210107 Published date: Version: 1.0.2
58951000210107
1.0.2
29/03/2026
LUNG NSCLC Metastatic - gefitinib Id: 59011000210103 Published date: Version: 1.0.2
59011000210103
1.0.2
29/03/2026

NON-Metastatic Regimens

Superseded Regimens Sort regimens by
LUNG NSCLC NON-Metastatic - alectinib Id: 52401000210103 Published date: Version: 3.0.2
52401000210103
3.0.2
29/03/2026
LUNG NSCLC NON-Metastatic - aTEZOLIzumab Id: 52771000210104 Published date: Version: 3.0.2
52771000210104
3.0.2
20/08/2025
LUNG NSCLC NON-Metastatic - crizotinib Id: 52861000210102 Published date: Version: 1.0.2
52861000210102
1.0.2
29/03/2026
LUNG NSCLC NON-Metastatic - durvalumab Id: 52781000210102 Published date: Version: 2.1.2
52781000210102
2.1.2
29/03/2026

SCLC Regimens

Published Sort regimens by
LUNG SCLC Extensive - cARBOplatin and etoposide Id: 58961000210105 Published date: Version: 3.0.0
58961000210105
3.0.0
25/07/2024
LUNG SCLC Extensive - cARBOplatin and oral etoposide Id: 58991000210100 Published date: Version: 3.0.0
58991000210100
3.0.0
25/07/2024
LUNG SCLC Extensive - cARBOplatin, etoposide and aTEZOLIzumab Id: 393231000210108 Published date: Version: 1.0.0
393231000210108
1.0.0
18/08/2024
LUNG SCLC Extensive - cARBOplatin, etoposide [IV/oral] and aTEZOLIzumab Id: 506281000210103 Published date: Version: 1.0.0
506281000210103
1.0.0
09/04/2025
LUNG SCLC Extensive - cARBOplatin, etoposide and durvalumab Id: 393221000210106 Published date: Version: 2.0.0
393221000210106
2.0.0
29/04/2025
LUNG SCLC Extensive - cARBOplatin, etoposide [IV/oral] and durvalumab Id: 506371000210109 Published date: Version: 1.0.0
506371000210109
1.0.0
01/05/2025
LUNG SCLC Extensive - CAV [CYCLOPHOSPHamide 1000, DOXOrubicin and vinCRISTine] Id: 52871000210108 Published date: Version: 2.0.0
52871000210108
2.0.0
08/05/2026
LUNG SCLC Extensive - CAV [CYCLOPHOSPHamide 750, DOXOrubicin and vinCRISTine] Id: 57371000210102 Published date: Version: 2.0.0
57371000210102
2.0.0
08/05/2026
LUNG SCLC Extensive - cISplatin and irinotecan Id: 58971000210104 Published date: Version: 2.0.0
58971000210104
2.0.0
01/04/2026
LUNG SCLC Extensive - PACLItaxel Q1W Id: 263891000210100 Published date: Version: 1.0.0
263891000210100
1.0.0
25/07/2024
LUNG SCLC Limited - cARBOplatin and etoposide Id: 57381000210100 Published date: Version: 3.0.0
57381000210100
3.0.0
26/07/2024
LUNG SCLC Limited - cISplatin and etoposide Id: 57391000210103 Published date: Version: 3.0.0
57391000210103
3.0.0
08/05/2026
LUNG SCLC Limited - cISplatin and etoposide 60/120 chemoradiation Id: 59001000210100 Published date: Version: 4.0.0
59001000210100
4.0.0
08/05/2026
LUNG SCLC Limited - cISplatin and etoposide 80/100 chemoradiation Id: 59521000210102 Published date: Version: 2.0.0
59521000210102
2.0.0
08/05/2026
LUNG SCLC Limited - durvalumab Q4W [flat dosing] Id: 506701000210103 Published date: Version: 1.0.0
506701000210103
1.0.0
26/02/2026